NCT04702633View on ClinicalTrials.gov

Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

127

Participants

Timeline

Start Date

March 19, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

May 30, 2022

Conditions
Prostate Cancer
Interventions
OTHER

Results obtained by biopsy and MRI results.

Results obtained by biopsy and MRI results.

OTHER

Clinical data

Clinical data

Trial Locations (1)

75014

Cochin Hospital, Paris

All Listed Sponsors
collaborator

Rarecells Diagnostics SAS

INDUSTRY

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04702633 - Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer | Biotech Hunter | Biotech Hunter